Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
EP 3791896
KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS
granted -
US 10946107
Polynucleotide agents targeting hydroxyacid oxidase (glycolate oxidase, HAO1) and methods of use thereof
granted -
US 10947254
Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
granted -
US 10947505
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 10947312
Human antibodies to GFRα3 and methods of making thereof
granted -
US 10947302
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them
granted -
US 10947277
Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays
granted -
US 10947238
Wee1 kinase inhibitors and methods of making and using the same
granted -
US 10947198
Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents
granted -
US 10946080
Compositions and methods for combination therapy with dengue virus and dendritic cells
granted -
US 10946047
Extracellular vesicles with enhanced potency
granted -
US 10946044
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10946009
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
granted -
US 10945988
Treatment of circadian rhythm disorders
granted -
US 10946065
Methods of treating fungal infections
granted -
US 10946106
Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
granted -
US 10947216
Amide compounds and method for making and using
granted -
US 10946308
Enzymatic method for extraction and purification of phytocannabinoids
granted -
US 10946096
Nitrobenzaldehyde proton release for manipulation of cellular acidosis
granted -
US 10946101
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
granted -
US 10946045
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 10946049
Use of gram negative species to treat atopic dermatitis
granted -
US 10946048
Use of gram negative species to treat atopic dermatitis
granted -
US 10946027
Tianeptine oxalate salts and polymorphs
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.